|Articles|May 18, 2011

Aurora Algae Preps for Large-Scale Algae Production

The new omega-3 player is producing algae-based omega-3 eicosapentaenoic acid (EPA).

Aurora Algae Pty. Ltd. (West Perth, Western Australia) has announced several new milestones in its production of algae-based biomass.

On top of Aurora Algae opening a 20-acre demonstration facility in Karratha, Western Australia, the company has also secured an option agreement for more than 1500 acres of land near its demo facility to construct a full-scale commercial manufacturing facility.

Aurora Algae has also received $946,000 AUD in LEEDS grant funding and $750,000 AUD in R&D tax credits from the Australian government in addition to previous LEEDS funding.

These initiatives will enable the company to speed up commercialization of its algae biomass, intended for a variety of applications including vegetarian omega-3 eicosapentaenoic acid (EPA).

Aurora Algae produces algae-based biomass for the nutraceutical, pharmaceutical, aquaculture, and renewable energy markets. The company owns a U.S. processing center in Hayward, California while producing biomass in the “ideal environmental conditions” of Western Australia.

Newsletter

From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.